Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Recent news and posts

Tags

Use tags to find relevant records
3D printed implants
Ablation methods
Allogeneic mesenchymal stem cells
Ambulatory ECG monitoring
Aortic abdominal aneurysm
Aortic root replacement
Arthroplasty
Arthroscopy
Assisted ventilation
Atherectomy
Austria
Autologous chondrocyte implantation
Automated external defibrillator
AV fistula
AV graft
Balloon kyphoplasty
Bariatric surgery
Baroreflex activation therapy
Barrett’s oesophagus
Belgium
Benign prostatic hyperplasia
Biopsy
Bone Conductive Hearing Device
Breast reconstruction
Bronchial thermoplasty
Burns
Caesarean section
Cancer
Capsule endoscopy
Carbon ion therapy
Cardiac ablation
Cardiac computer tomography
Cardiac pacemaker
Cardiac resynchronization therapy
Cardiac Resynchronization Therapy Defibrillator (CRT-D)
Cardiovascular devices
Cardiovascular procedures
Carotid endarterectomy
Cataract
Cell therapy
Cholecystectomy
Chronic obstructive pulmonary disease
Chronic wounds
Clinical guidelines
Cochlear implants
Commissioning
Companion diagnostic tests
Computed tomography
Conditional reimbursement
Connected medical devices
Continuous glucose monitoring (CGM)
Coronary interventions
Coronary percutaneous revascularization procedures
Coronary procedures
Coronavirus
Coverage with evidence development (CED)
See all tags

Representative of French Ministry of Health has commented on the article describing challenges of innovating funding program (“Forfait Innovation”)

Cédric Carbonneil from the Ministry of Health published a letter in Value in Health in response to the article "New French Coverage with Evidence Development for Innovative Medical Devices: Improvements and Unresolved Issues" published in January 2016. Dr Carbonneil offers an interesting insights into background, rationale and direction of development of this important coverage with evidence development program for medical devices, in-vitro diagnostics and medical procedures in France.

Read original article "New French Coverage with Evidence Development for Innovative Medical Devices: Improvements and Unresolved Issues" here. 

Read response from Cédric Carbonneil here.  

Read more about Innovation Funding scheme at the web-site of National Authority for Health (HAS) in French here.

Subscribe to our biweekly newsletter not to miss important reimbursement information.

Tags
France
Innovation funding

The latest related news

15
Jan 2025

Recommendations about add-on reimbursement for medical devices in France in December 2024

The French National Authority for Health (HAS) released new recommendations about add-on reimbursement of medical devices and medical aids from the December 2024 meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS). Three favorable opinions were published concerning the registration of new medical devices in the List of Reimbursable Products and Services (LPPR). They relate to breast reconstruction and medical aids.
Read more
08
Jan 2025

New CCAM codes to be introduced in France

On December 24, 2024, the decision of the National Union of Health Insurance Funds (UNCAM) regarding the update of the CCAM Classification of procedure codes was published in the Official Journal of the French Republic. Changes include registration of three new procedure codes, modification of billing notes for certain procedures, and amendment of modifiers. The updates are expected to come into force on February 1, 2025.
Read more
24
Dec 2024

Dutch ZonMw accepts applications for grants under the “Effectiveness Study 2026” round of the Efficiency Research program

On December 17, 2024, the Dutch Organization for Health Research and Development (ZonMw) announced the submission of grant applications for the subsidy round “Effectiveness Study 2026” of the Efficiency Research program, which is intended for projects to increase knowledge for healthcare practice about the effectiveness and costs of interventions in the Netherlands. The deadline for the submission of the applications is March 4, 2025.
Read more
12
Dec 2024

The Innovation Ecosystem Programme report was published in England

On November 28, 2024, NHS England published a report summarising the Innovation Ecosystem Programme’s (IEP) findings and recommendations for the next steps. The IEP aimed to foster collaboration between the NHS and key stakeholders (industry, academia, and regulators) to streamline healthcare innovation. Recommendations are summarised in four areas: a) setting the direction, b) structures and tools for delivery, c) people, skills, and capabilities, and d) acceleration.
Read more